OBJECTIVE: We present early life mortality rates in a largely rural population with high antenatal HIV prevalence, and investigate temporal and spatial associations with a prevention of mother-to-child transmission (PMTCT) programme, an HIV treatment programme, and maternal HIV. DESIGN: A retrospective cohort analysis. METHODS: All births from January 2000 to January 2007 to women in the Africa Centre demographic surveillance were included. Under-two child mortality rates (U2MR) computed as deaths per 1000 live-births per year; factors associated with mortality risk assessed with Weibull regression. Availability of PMTCT (single-dose nevirapine; sdNVP) and antiretroviral therapy (ART) in a programme included in multivariable analysis. RESULTS: Eight hundred and forty-eight (6.2%) of 13 583 children under 2 years died. Deaths in under-twos declined by 49% between 2001 and 2006, from 86.3 to 44.1 deaths per thousand live-births. Mortality was independently associated with birth season (adjusted hazard ratio 1.16, 95% confidence interval 1.02-1.33), maternal education (1.21, 1.02-1.43), maternal HIV (4.34, 3.11-6.04) and ART availability (0.46, 0.33-0.65). Children born at home (unlikely to have received sdNVP) had a 35% higher risk of dying than children born in a facility where sdNVP was available (1.35, 1.04-1.74). For 2005 births the availability of PMTCT and ART in public health programmes would have explained 8 and 31% of the decline in U2MR since 2000. CONCLUSION: These findings confirm the importance of maternal survival, and highlight the importance of the PMTCT and especially maternal HIV treatment with direct benefits of improved survival of their young children.
OBJECTIVE: We present early life mortality rates in a largely rural population with high antenatal HIV prevalence, and investigate temporal and spatial associations with a prevention of mother-to-child transmission (PMTCT) programme, an HIV treatment programme, and maternal HIV. DESIGN: A retrospective cohort analysis. METHODS: All births from January 2000 to January 2007 to women in the Africa Centre demographic surveillance were included. Under-two child mortality rates (U2MR) computed as deaths per 1000 live-births per year; factors associated with mortality risk assessed with Weibull regression. Availability of PMTCT (single-dose nevirapine; sdNVP) and antiretroviral therapy (ART) in a programme included in multivariable analysis. RESULTS: Eight hundred and forty-eight (6.2%) of 13 583 children under 2 years died. Deaths in under-twos declined by 49% between 2001 and 2006, from 86.3 to 44.1 deaths per thousand live-births. Mortality was independently associated with birth season (adjusted hazard ratio 1.16, 95% confidence interval 1.02-1.33), maternal education (1.21, 1.02-1.43), maternal HIV (4.34, 3.11-6.04) and ART availability (0.46, 0.33-0.65). Children born at home (unlikely to have received sdNVP) had a 35% higher risk of dying than children born in a facility where sdNVP was available (1.35, 1.04-1.74). For 2005 births the availability of PMTCT and ART in public health programmes would have explained 8 and 31% of the decline in U2MR since 2000. CONCLUSION: These findings confirm the importance of maternal survival, and highlight the importance of the PMTCT and especially maternal HIV treatment with direct benefits of improved survival of their young children.
Authors: Nigel C Rollins; Hoosen M Coovadia; Ruth M Bland; Anna Coutsoudis; Michael L Bennish; Deven Patel; Marie-Louise Newell Journal: J Acquir Immune Defic Syndr Date: 2007-03-01 Impact factor: 3.731
Authors: Basia Zaba; Jimmy Whitworth; Milly Marston; Jessica Nakiyingi; Anthony Ruberantwari; Mark Urassa; Raphaeli Issingo; Gabriel Mwaluko; Sian Floyd; Andrew Nyondo; Amelia Crampin Journal: Epidemiology Date: 2005-05 Impact factor: 4.822
Authors: Hoosen M Coovadia; Nigel C Rollins; Ruth M Bland; Kirsty Little; Anna Coutsoudis; Michael L Bennish; Marie-Louise Newell Journal: Lancet Date: 2007-03-31 Impact factor: 79.321
Authors: Brian D Rice; Jörg Bätzing-Feigenbaum; Victoria Hosegood; Frank Tanser; Caterina Hill; Till Barnighausen; Kobus Herbst; Tanya Welz; Marie-Louise Newell Journal: BMC Public Health Date: 2007-07-18 Impact factor: 3.295
Authors: Eric Remera; Frédérique Chammartin; Sabin Nsanzimana; Jamie Ian Forrest; Gerald E Smith; Placidie Mugwaneza; Samuel S Malamba; Muhammed Semakula; Jeanine U Condo; Nathan Ford; David J Riedel; Marie Paul Nisingizwe; Agnes Binagwaho; Edward J Mills; Heiner Bucher Journal: BMJ Glob Health Date: 2021-05
Authors: Janet M Turan; Abigail H Hatcher; José Medema-Wijnveen; Maricianah Onono; Suellen Miller; Elizabeth A Bukusi; Bulent Turan; Craig R Cohen Journal: PLoS Med Date: 2012-08-21 Impact factor: 11.069
Authors: Samuel J Clark; Kathleen Kahn; Brian Houle; Adriane Arteche; Mark A Collinson; Stephen M Tollman; Alan Stein Journal: PLoS Med Date: 2013-03-26 Impact factor: 11.069